/term/debt-to-ebitda/SHSE:688075 Assure Tech (Hangzhou) Co (SHSE:688075) Debt-to-EBITDA
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assure Tech (Hangzhou) Co Ltd (SHSE:688075) » Definitions » Debt-to-EBITDA

Assure Tech (Hangzhou) Co (SHSE:688075) Debt-to-EBITDA : 0.11 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Assure Tech (Hangzhou) Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Assure Tech (Hangzhou) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥5.4 Mil. Assure Tech (Hangzhou) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥6.0 Mil. Assure Tech (Hangzhou) Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ¥105.7 Mil. Assure Tech (Hangzhou) Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.11.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Assure Tech (Hangzhou) Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:688075' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.83   Med: 0.01   Max: 0.09
Current: 0.08

During the past 7 years, the highest Debt-to-EBITDA Ratio of Assure Tech (Hangzhou) Co was 0.09. The lowest was -14.83. And the median was 0.01.

SHSE:688075's Debt-to-EBITDA is ranked better than
86.3% of 270 companies
in the Biotechnology industry
Industry Median: 1.31 vs SHSE:688075: 0.08

Assure Tech (Hangzhou) Co Debt-to-EBITDA Historical Data

The historical data trend for Assure Tech (Hangzhou) Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assure Tech (Hangzhou) Co Debt-to-EBITDA Chart

Assure Tech (Hangzhou) Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial - - 0.01 0.01 0.08

Assure Tech (Hangzhou) Co Quarterly Data
Dec17 Dec18 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.06 -0.06 0.03 0.11

Competitive Comparison of Assure Tech (Hangzhou) Co's Debt-to-EBITDA

For the Biotechnology subindustry, Assure Tech (Hangzhou) Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assure Tech (Hangzhou) Co's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assure Tech (Hangzhou) Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Assure Tech (Hangzhou) Co's Debt-to-EBITDA falls into.



Assure Tech (Hangzhou) Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Assure Tech (Hangzhou) Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.411 + 8.171) / 208.947
=0.07

Assure Tech (Hangzhou) Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.411 + 5.99) / 105.712
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Assure Tech (Hangzhou) Co  (SHSE:688075) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Assure Tech (Hangzhou) Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Assure Tech (Hangzhou) Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Assure Tech (Hangzhou) Co (SHSE:688075) Business Description

Traded in Other Exchanges
N/A
Address
No. 1418-50,Moganshan Road, Building 4, Gongshu District, Hangzhou, CHN
Assure Tech (Hangzhou) Co Ltd is a biotechnology company. The company is engaged in research & development, production, sell of diagnostic reagents, POCT and biological materials.

Assure Tech (Hangzhou) Co (SHSE:688075) Headlines

No Headlines